Recent Acquisition Collegium Pharmaceutical recently acquired Ironshore Pharmaceuticals Inc. for $525 million in cash, indicating potential expansion of product portfolio and market reach. This acquisition presents an opportunity for cross-selling products to existing and new customers.
Investor Interest Various investment firms like Caxton Investments, Johnson Investment Counsel, and Ritholtz Wealth Management have recently made significant investments in Collegium Pharmaceutical, showing investor confidence in the company's growth potential. This investor interest could be leveraged to explore partnership opportunities and further drive sales.
Recognition in Industry Collegium Pharmaceutical was recognized as a top player in the Drug Manufacturers - Specialty & Generic industry. This recognition enhances the company's credibility and can open doors for collaboration with key industry players, leading to increased sales opportunities.
ESG Report Launch Collegium Pharmaceutical launched its Environmental, Social, and Governance (ESG) report, emphasizing its commitment to sustainability and social responsibility. This focus on ESG can appeal to customers looking for ethically conscious partners, providing a unique selling point and potentially driving sales growth.
Financial Strength With a revenue in the range of $50-100 million and significant funding of $203 million, Collegium Pharmaceutical demonstrates financial stability and growth potential. This financial strength can instill confidence in potential clients and partners, facilitating sales conversations and deals.
Collegium Pharmaceutical, Inc. uses 8 technology products and services including jQuery CDN, Drupal, Font Awesome, and more. Explore Collegium Pharmaceutical, Inc.'s tech stack below.
| Collegium Pharmaceutical, Inc. Email Formats | Percentage |
| FLast@collegiumpharma.com | 50% |
| FLast@collegiumpharma.com | 50% |
Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees
Collegium Pharmaceutical is building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a portfolio of differentiated medications to treat serious medical conditions.
Company Overview
Media & News
Funding & FinancialsCollegium Pharmaceutical, Inc. has raised a total of $203M of funding over 9 rounds. Their latest funding round was raised on Feb 07, 2023 in the amount of $203M.
Collegium Pharmaceutical, Inc.'s revenue is in the range of $50M$100M
Funding & FinancialsCollegium Pharmaceutical, Inc. has raised a total of $203M of funding over 9 rounds. Their latest funding round was raised on Feb 07, 2023 in the amount of $203M.
Collegium Pharmaceutical, Inc.'s revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com